Skip to main content

Boteraser | Website and Server Security Solutions

🛡️ CVE-2025-20142 — ios-xr

🟠 CVSS 8.6 — High ✅ No Known Exploit CWE-20 NVD
8.6
CVSS Score
0 Low4 Medium7 High9 Critical10

Description

A vulnerability in the IPv4 access control list (ACL) feature and quality of service (QoS) policy feature of Cisco IOS XR Software for Cisco ASR 9000 Series Aggregation Services Routers, ASR 9902 Compact High-Performance Routers, and ASR 9903 Compact High-Performance Routers could allow an unauthenticated, remote attacker to cause a line card to reset, resulting in a denial of service (DoS) condition.

This vulnerability is due to the incorrect handling of malformed IPv4 packets that are received on line cards where the interface has either an IPv4 ACL or QoS policy applied. An attacker could exploit this vulnerability by sending crafted IPv4 packets through an affected device. A successful exploit could allow the attacker to cause network processor errors, resulting in a reset or shutdown of the network process. Traffic over that line card would be lost while the line card reloads.

Note: This vulnerability has predominantly been observed in Layer 2 VPN (L2VPN) environments where an IPv4 ACL or QoS policy has been applied to the bridge virtual interface. Layer 3 configurations where the interface has either an IPv4 ACL or QoS policy applied are also affected, though the vulnerability has not been observed.

How this vulnerability can be exploited

This issue can be reached over the network, attack complexity is low, an attacker needs no privileges on the target. No user interaction is required. The scope is changed, meaning a successful attack can affect components beyond the vulnerable one. Rated impact: confidentiality none, integrity none, availability high.

CVSS metrics in full

The score comes from this vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:N/I:N/A:H

  • Attack vector: Network — reachable from anywhere that can route to the service.
  • Attack complexity: Low — the attack works reliably, with no preparation.
  • Privileges required: None — an unauthenticated stranger can try it.
  • User interaction: None — nobody has to be tricked into anything.
  • Scope: Changed — a successful attack reaches components beyond the vulnerable one.
  • Confidentiality impact: None.
  • Integrity impact: None.
  • Availability impact: High — total loss, or loss the attacker controls.

Weakness class

CVE-2025-20142 is classified as CWE-20: Improper Input Validation. The application accepts input without checking that it has the expected form, so malformed values reach code that assumes they are well formed.

Affected software

CVE-2025-20142 is recorded against 1 package.

  • ios-xr

Timeline and source

Published on 12 March 2025 and last revised on 17 June 2026. No public exploit is currently recorded for this entry. Record sourced from NVD.

References

blog.apnic.net
sec.cloudapps.cisco.com

Other advisories for this package

ios-xr has other advisories on record. If you are patching this one, these are worth checking on the same host:

Same weakness in other software

These advisories are the same class of weakness (CWE-20: Improper Input Validation) in other software:

Details

Severity HIGH
CVSS Score 8.6
CVSS Vector CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:N/I:N/A:H
CWE CWE-20
Public Exploit ✅ No
Source NVD
Published 2025-03-12
Updated 2026-08-20
Modified 2026-06-17
Fix URL N/A

Affected Packages

Software From version Fixed in
ios-xr — —

Similar Threats

Site Security Check

Is ios-xr part of your stack?

CVE-2025-20142 is rated CVSS 8.6 High. BotEraser scans your installation against known CVE records and tells you whether this vulnerability applies to the versions you actually run.

Scan My Site Free →

No credit card required  ·  Results in minutes

ⓘ Data Notice: The information presented above has been compiled from publicly available internet sources. Boteraser aggregates this data solely for informational purposes and does not independently classify, evaluate, or endorse any findings about the vulnerabilities listed. The accuracy and completeness of this information is the sole responsibility of the original publishers. Boteraser and its operators accept no liability for any decisions made based on this data.

Browse related advisories

All advisoriesCVECVE 2025
✓